On the public citation graph

Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients - A Prospective Randomized Controlled Phase III Study

https://doi.org/10.2139/ssrn.4596447
0 signed · 26 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamaoncol.2018.5896openalex-extracted
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
inferredcites →https://doi.org/10.1002/bjs.10984openalex-extracted
Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
inferredcites →https://doi.org/10.1002/bjs.11220openalex-extracted
Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer
inferredcites →https://doi.org/10.1002/jso.10308openalex-extracted
Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection
inferredcites →https://doi.org/10.1016/j.asjsur.2021.01.011openalex-extracted
Persistent extramural vascular invasion positivity on magnetic resonance imaging after neoadjuvant chemoradiotherapy predicts poor outcome in rectal cancer
inferredcites →https://doi.org/10.1016/j.clcc.2020.12.005openalex-extracted
Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges
inferredcites →https://doi.org/10.1016/s1470-2045(15)00120-5openalex-extracted
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
inferredcites →https://doi.org/10.1016/s1470-2045(20)30555-6openalex-extracted
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
inferredcites →https://doi.org/10.1056/nejmoa2303269openalex-extracted
Preoperative Treatment of Locally Advanced Rectal Cancer
inferredcites →https://doi.org/10.1093/annonc/mdx224openalex-extracted
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
inferredcites →https://doi.org/10.1097/01.sla.0000133083.54934.aeopenalex-extracted
Classification of Surgical Complications
inferredcites →https://doi.org/10.1097/01.sla.0000141194.27992.32openalex-extracted
Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy
inferredcites →https://doi.org/10.1097/sla.0000000000005780openalex-extracted
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
inferredcites →https://doi.org/10.1111/j.1365-2559.2007.02720.xopenalex-extracted
Colorectal tumour deposits in the mesorectum and pericolon; a critical review
inferredcites →https://doi.org/10.1136/bmj.c332openalex-extracted
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
inferredcites →https://doi.org/10.1200/jco.20.01932openalex-extracted
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer
inferredcites →https://doi.org/10.1200/jco.2009.25.8376openalex-extracted
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
inferredcites →https://doi.org/10.1200/jco.2010.34.4911openalex-extracted
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2011.29.15_suppl.3503openalex-extracted
The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04.
inferredcites →https://doi.org/10.1200/jco.2011.37.7176openalex-extracted
Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer
inferredcites →https://doi.org/10.1200/jco.2012.42.8771openalex-extracted
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.3500openalex-extracted
Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial.
inferredcites →https://doi.org/10.1200/jco.2016.66.6198openalex-extracted
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2016.67.6049openalex-extracted
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
inferredcites →https://doi.org/10.1200/jco.2020.38.15_suppl.4008openalex-extracted
Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
inferredcites →https://doi.org/10.3322/(issn)1542-4863openalex-extracted
CA: A Cancer Journal for Clinicians
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.